What MagView does

MagView is a privately held mammography information system (MIS) software company founded in 1990 and originally developed for the American College of Radiology as the first BI-RADS structured reporting system. The company provides a modular software platform for U.S. breast imaging centers covering patient tracking, structured radiology reporting, MQSA compliance, workflow automation, patient navigation, and breast cancer risk assessment. Its core architecture combines the MagView MIS platform with the proprietary MagLink integration suite (supporting HL7, DICOM, and web APIs), the MagTAC interface monitor, and the Luminary Risk module for high-risk screening, which integrates the Tyrer-Cuzick v8.0 (IBIS) risk model alongside the FDA-authorized Clairity Breast AI image-based risk assessment and Myriad Genetics' hereditary cancer testing. MagView serves over 2,500 breast imaging facilities in the United States, with stated penetration of approximately 50% of the top 25 cancer hospitals, and is the only vendor with full NQMBC 2.0 certified software.

The company operates an enterprise direct-sales go-to-market motion with "Request a Demo" CTAs and quote-based pricing, targeting cancer centers, academic medical centers, large health systems, outpatient imaging providers, VA hospitals, and private radiology practices. Revenue is generated primarily through annual subscription licenses for the core MIS and modular add-ons, supplemented by implementation, configuration, training, and integration professional services. Notable named customers include CARTI Cancer Center, University of Virginia, MemorialCare Health System, SimonMed Imaging, Rayus Radiology, Houston Methodist, Penn State Health, Denver Health, Emory Winship Cancer Institute, and Steinberg Diagnostic Medical Imaging (SDMI). Long-standing technology partnerships include Hologic (co-developer of the Unifi EQUIP quality compliance software), Epic, Nuance, and the National Consortium of Breast Centers (NCoBC), and recent strategic collaborations include Clairity and Myriad Genetics to deliver an integrated AI and genetic risk assessment platform launched in November 2025.

The company is headquartered in Fulton, Maryland, employs 51-100 people, and is privately held with no disclosed parent company, outside investors, or funding rounds. MagView is also beginning to extend beyond breast imaging with a referenced Lung Screening offering (lungview.com), indicating modest adjacent-vertical expansion.

Name

MagView

Legal name

MagView

Website

https://magview.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

51–100 employees

Short description

MagView is a privately held mammography information system software company founded in 1990 that serves over 2,500 U.S. breast imaging facilities with workflow, reporting, risk assessment, and MQSA compliance tools, including the Luminary Risk module with FDA-authorized AI.

Ownership category

akta.pro rank

Product category

Mammography Information Systems / Breast Imaging Workflow Software

NAICS

Software Publishers (513210), Software Publishers (5132)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL)

akta.pro secondary industries

Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD)

Keywords

• Mammography information systems
• Breast imaging workflow software
• BI-RADS structured reporting
• MQSA compliance software
• Breast cancer risk assessment

Headquarters

HQ city

Fulton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

1. Mammography Information System Software Licenses: MagView provides mammography tracking and reporting software to breast imaging centers, likely through annual or multi-year software licenses with implementation and support services included.
2. Risk Assessment Software (Luminary Risk): High-risk breast cancer screening software sold to imaging facilities and healthcare providers for personalized risk assessment and patient management.
3. Professional Services and Implementation: Implementation, configuration, and training services for breast imaging facilities deploying MagView software solutions.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

MagView sells a mammography information system (MIS) software platform that helps breast imaging centers automate patient tracking, perform BI-RADS structured radiology reporting, manage MQSA compliance, run patient navigation, and conduct high-risk breast cancer risk assessment via its Luminary Risk module. The platform is sold primarily through direct enterprise sales to U.S. breast imaging centers, cancer centers, hospital systems, and radiology practices on a subscription/annual license basis, with implementation and support services included.

Product overview

MagView is a mammography information system (MIS) — a comprehensive, modular software platform for breast imaging centers. The core MagView platform provides patient tracking, mammography reporting, workflow automation, MQSA compliance, and analytics, upon which specialized modules are built. Key modules include: Mammography Tracking Software (automated patient tracking and follow-up), Radiology Reporting Software (BI-RADS structured and dictation-based reporting), Workflow Solutions (TechPad, patient experience tools), Compliance & Analytics (MQSA compliance), and Patient Navigation (care continuum tracking). The product suite is anchored by Luminary Risk — MagView's breast cancer risk assessment platform that integrates Tyrer-Cuzick and other risk models, and which now incorporates Clairity Breast (FDA-authorized AI image-based risk assessment) and connects to Myriad Genetics MyRisk hereditary cancer testing. A free online Tyrer-Cuzick Risk Calculator is also offered for patient-facing use. The platform serves more than 2,500 facilities across the United States.

Differentiator

Problem solved

Functional benefit

Brands

• Luminary Risk: High-risk breast cancer screening software for identifying and managing high-risk patients with support for unique workflows and facilities of any size.
• MagView TechPad
• MagLink
• MagTAC

Products and services

• MagView Mammography Information System Core mammography information system (MIS) platform for breast imaging centers providing patient tracking, mammography reporting, workflow automation, MQSA compliance, and analytics. Sold to U.S. breast imaging centers, cancer centers, and radiology practices via direct enterprise sales.
• Luminary Risk High-risk breast cancer risk assessment platform integrating the Tyrer-Cuzick v8.0 (IBIS) risk model and Clairity Breast AI image-based risk assessment, with automated risk scoring, care pathway recommendations, and patient communication. Available in two versions: Luminary Risk for Breast Imaging and Luminary Risk for Providing Physicians.
• Clairity Breast AI Image-Based Risk Assessment First and only FDA-authorized AI image-based breast cancer risk assessment that analyzes mammogram images to estimate a woman's five-year risk of developing breast cancer, now natively available within the Luminary Risk workflow software for breast imaging facilities.
• Tyrer-Cuzick (IBIS) Risk Calculator Online breast cancer risk assessment tool using the Tyrer-Cuzick v8 (IBIS) risk model that estimates a patient's chance of developing breast cancer based on personal and family health history. Free non-clinical version for patients; clinical licenses available for facilities.
• Mammography Tracking Software Automated patient tracking module that ensures no patient falls through the cracks with automated lay letters, reminders, and actionable reports. Includes automated BI-RADS, breast density, risk score, and recommendation extraction from dictated reports and MQSA compliance tracking. Sold to breast imaging centers as part of the MagView platform.
• Radiology Reporting Software Flexible BI-RADS reporting module for breast radiologists with one-click negatives for screening mammograms, smart data capture from dictated reports, voice dictation integration, and full patient visibility including risk scores and history. Sold as part of the MagView platform.
• Workflow Solutions Comprehensive breast imaging facility workflow solution including TechPad mobile workstation, integrated history collection, patient status board, advanced breast diagram, and integrations with EMR, RIS, PACS, and dictation systems. Sold to breast imaging facilities.
• Compliance & Analytics MQSA compliance and analytics module that streamlines certification and compliance for breast imaging centers. Includes quality assurance dashboard, audit support, document management, real-time alerts, built-in MQSA reporting tools, outcome statistics calculations, and automated oversight of the EQUIP process. Sold to breast imaging facilities.
• Patient Navigation Cancer patient navigation system that tracks patients through the continuum of care from imaging through treatment and beyond. Features user-defined navigation worklists, automated reminders, overdue follow-up flags, integrated imaging and pathology results, and customizable stages based on NCBC Navigation Matrix. Sold to breast centers.
• Patient Experience Tools Suite of patient-facing tools including automated text messaging reminders, Patient History Portal (HIPAA-compliant online pre-visit questionnaires), Patient Tablet Module (in-office electronic forms with 95% adoption at some facilities), and Patient Results Portal (HIPAA-compliant access to lay letters). Sold to breast imaging centers.
• TechPad Mobile Workstation Mobile technologist workflow tool that untethers technologists from desktop workstations, allowing them to move freely with patients, receive instant radiologist feedback, update patient status immediately, and reduce waiting time. Sold to breast imaging facilities.
• MagLink Integration Suite First and only vendor-created integration suite enabling complex workflows via HL7, DICOM, and web APIs. Custom-written interfaces enable seamless connection with EHR, RIS, PACS, dictation systems, and other breast imaging technology systems. Sold as part of the MagView platform.
• MagTAC Interface Monitor Real-time monitoring system that verifies proper functioning of database and interfaces, promptly alerting support team for minimal interface downtimes. Sold as part of the MagView platform to breast imaging facilities.
• Integrated AI and Genetic Risk Platform Unified AI and genetic risk assessment platform combining Clairity Breast AI image-based risk assessment, Myriad's MyRisk Hereditary Cancer Test with RiskScore, and MagView's Luminary Risk workflow software for comprehensive personalized breast cancer risk assessment. Available through MagView's platform to 2,500+ U.S. breast imaging facilities.

Quantifiable outcome

• Over 2,500 breast imaging facilities rely on MagView software
• +3 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability4 records

Feature13 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Myriad GeneticscoreTechnology or Integration · 25 November 2025Strategic collaboration to integrate Myriad's genetic testing capabilities (MyRisk Hereditary Cancer Test with RiskScore) with MagView's Luminary Risk platform for comprehensive breast cancer risk assessment. The integrated platform combines Clairity Breast AI image-based risk, Myriad's genetic testing, and MagView's workflow software into a unified tool for personalized breast health management.
• ClairitycoreTechnology or Integration · 25 November 2025Integration partnership to bring Clairity Breast, the first and only FDA-authorized AI image-based breast cancer risk assessment, into MagView's Luminary Risk platform. Clairity Breast analyzes mammogram images to estimate five-year breast cancer risk, identifying high-risk women who may be missed by traditional models.
• Know Your Lemons FoundationminorGTM or Marketing Partner · 5 November 2025Partnership to help breast centers improve screening rates by combining MagView's workflow solutions with Know Your Lemons' innovative breast health education using a simple, lemon-based visual system to teach signs of breast cancer.
• HologiccoreTechnology or Integration · 1 January 2019Long-standing tight integration partnership with Hologic, leaders in breast imaging technology. Jointly developed the award-winning Unifi EQUIP software solution released in 2019 for mammography quality compliance.
• Epic (EHR Integration)coreTechnology or IntegrationIntegration partnership enabling seamless data exchange between MagView's mammography software and Epic's electronic health record system, commonly used by many breast centers.
• American College of Radiology (ACR)coreStrategic or Co-development PartnerMagView was originally founded by the ACR and developed as the first BI-RADS structured reporting system. Ongoing collaboration for MQSA compliance, BI-RADS standards, and breast imaging excellence.
• DNA Visit (Genetic Counseling)minorChannel Partner/ Reseller/ DistributorVirtual care partnership providing patients access to board-certified genetic counselors from DNA Visit for hereditary cancer testing consultation through MagView's patient portal.
• National Consortium of Breast Centers (NCoBC)coreStrategic or Co-development PartnerNCoBC elected MagView to lead development of the NQMBC 2.0 Vendor Certification Program. MagView is the first and remains the only certified software supporting NQMBC 2.0.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Hologic: Hologic is a leading breast imaging hardware OEM and a strategic partner of MagView (co-developed Unifi EQUIP). As a broad incumbent, it offers SecurView diagnostic workstations and increasingly competes at the workflow layer via its own mammography software stack.
• Epic Systems (Beaker): Epic's Beaker LIS and imaging modules are integrated with MagView via MagLink but also offer native structured reporting and workflow capabilities that increasingly compete with specialty mammography software at large health systems.

Emerging players

• Koios Medical: Koios Medical offers AI decision-support for breast and thyroid ultrasound, with breast applications that overlap with MagView's risk-assessment and reporting modules for downstream supplemental imaging.
• CureMetrix: CureMetrix develops AI-based mammography CADt and triage algorithms that integrate into breast imaging reporting workflows. It competes at the AI image-based risk and detection layer that MagView addresses via Clairity.
• iCAD: iCAD offers ProFound AI for breast cancer detection and risk assessment, integrating into mammography reporting workflows. It competes with MagView's Clairity-integrated Luminary Risk on AI image-based risk and detection.
• Densitas: Densitas provides AI-driven breast density assessment and quality assurance tools integrated with mammography reporting workflows. It overlaps with MagView's density extraction and risk modules and represents a more specialized AI-native competitor.
• Volpara Health Technologies (Lunit): Volpara (acquired by Lunit) provides AI-driven breast density, risk, and reporting software to breast imaging centers. It overlaps with MagView's Luminary Risk module and is an emerging AI-native competitor with a cloud-first architecture.

Direct peers

• PenRad Technologies: PenRad is a direct competitor to MagView, providing mammography reporting, patient tracking, and MQSA/EQUIP compliance software to breast imaging centers across the United States. It overlaps most closely with MagView's core MIS and reporting modules.
• MRS Systems: MRS Systems (Mammography Reporting System) is a long-standing direct competitor offering structured mammography reporting, patient tracking, and breast center workflow software—overlapping with MagView's tracking and reporting modules.

Others

• Nuance (Microsoft) PowerScribe: Nuance's PowerScribe dictation platform is integrated by MagView for radiology reporting, but Microsoft/Nuance also offers broader radiology reporting and structured reporting capabilities that could expand into the mammography reporting niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/magviewinc
• YouTubeyoutube.com/channel/UCpuMpNokhqQbRBvDPXpyyyw
• Facebookfacebook.com/magviewinc
• LinkedInlinkedin.com/company/magview

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MagView